DCM
MGNX icon

DAFNA Capital Management’s MacroGenics MGNX Stock Holding History

DAFNA Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-152,250
Closed -$1.46M – 77
2023
Q4 		$1.46M Sell
152,250
-106,246
-41% -$734K 0.35% 52
2023
Q3 		$1.2M Buy
+258,496
New +$1.29M 0.37% 52
2023
Q1 		– Sell
-39,879
Closed -$268K – 78
2022
Q4 		$268K Sell
39,879
-60,121
-60% -$330K 0.08% 70
2022
Q3 		$346K Sell
100,000
-92,000
-48% -$352K 0.09% 81
2022
Q2 		$566K Hold
192,000
– – 0.15% 72
2022
Q1 		$1.69M Buy
192,000
+102,000
+113% +$1.13M 0.44% 54
2021
Q4 		$1.45M Hold
90,000
– – 0.36% 55
2021
Q3 		$1.89M Buy
+90,000
New +$2.17M 0.5% 50
2020
Q2 		– Sell
-150,000
Closed -$873K – 90
2020
Q1 		$873K Hold
150,000
– – 0.36% 55
2019
Q4 		$1.63M Sell
150,000
-50,000
-25% -$495K 0.56% 42
2019
Q3 		$2.55M Buy
200,000
+150,000
+300% +$2.16M 0.96% 28
2019
Q2 		$849K Hold
50,000
– – 0.32% 61
2019
Q1 		$899K Sell
50,000
-28,305
-36% -$489K 0.39% 54
2018
Q4 		$994K Hold
78,305
– – 0.49% 49
2018
Q3 		$1.68M Hold
78,305
– – 0.69% 41
2018
Q2 		$1.62M Sell
78,305
-4,800
-6% -$108K 0.76% 38
2018
Q1 		$2.09M Sell
83,105
-71,095
-46% -$1.73M 1.02% 31
2017
Q4 		$2.93M Hold
154,200
– – 1.58% 21
2017
Q3 		$2.85M Buy
154,200
+35,000
+29% +$606K 1.77% 17
2017
Q2 		$2.09M Hold
119,200
– – 1.49% 22
2017
Q1 		$2.22M Buy
119,200
+30,000
+34% +$579K 1.88% 17
2016
Q4 		$1.82M Buy
89,200
+35,000
+65% +$881K 1.6% 25
2016
Q3 		$1.62M Hold
54,200
– – 1.13% 31
2016
Q2 		$1.46M Hold
54,200
– – 1.16% 28
2016
Q1 		$1.02M Buy
54,200
+30,200
+126% +$575K 0.88% 36
2015
Q4 		$743K Hold
24,000
– – 0.66% 41
2015
Q3 		$514K Buy
+24,000
New +$753K 0.51% 55

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

DAFNA Capital Management's MGNX Position: Q1 2024 in Review

DAFNA Capital Management sold out of MacroGenics (MGNX) in Q1 2024, closing a stake of 152,250 shares — an estimated $1.46M sold.

DAFNA Capital Management first reported a position in MGNX in Q3 2015 and held it in 27 quarters. The position peaked at $2.93M in Q4 2017. 163 funds tracked by Wall St. Rank hold MGNX as of Q1 2024.

  • DAFNA Capital Management reported no remaining MacroGenics position as of Q1 2024 after selling out during the quarter.
  • DAFNA Capital Management sold 152,250 MacroGenics shares in Q1 2024, an estimated $1.46M.
  • DAFNA Capital Management first reported a position in MacroGenics in Q3 2015 and held it in 27 quarters.
  • DAFNA Capital Management's MacroGenics position peaked at $2.93M in Q4 2017.
  • 163 funds tracked by Wall St. Rank held MacroGenics as of Q1 2024.

Based on DAFNA Capital Management's 13F filing for Q1 2024, filed 15 May 2024.